Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023April 30, 2024 Avecho Biotechnology saw revenue from ordinary activities fall 41% to A$446k in the half year to […]
Avecho raises another A$6m to fund trial as firm enters ‘defining chapter’ by Steve Jones August 28, 2023April 30, 2024
Avecho looks to Authorised Prescribers to find optimal dose for new fast-onset THC gummies by Steve Jones August 9, 2023August 21, 2023
Avecho completes development of fast-onset CBD gummy product by Martin Lane June 14, 2023April 30, 2024
Avecho plots A$11m capital raise to underpin CBD clinical trial by Steve Jones April 3, 2023April 30, 2024
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022April 29, 2024
Modern medicine: can the dominance of oil and flower be challenged? by Steve Jones October 6, 2022April 29, 2024
Avecho ‘adamant’ that S3 insomnia trial must be accepted overseas by Steve Jones May 4, 2022April 29, 2024
Avecho’s topical CBD gel shows promise in treating osteoarthritis by Martin Lane March 29, 2022April 29, 2024
Company news: Cann Global; Incannex; Creso Pharma; Rua Bioscience; Avecho; InhaleRx; Greenfern Industries; MGC Pharma by cannabiz team March 3, 2022April 29, 2024
